Successful treatment with efgartigimod as an add-on therapy for acute attack of anti-NMDA receptor encephalitis: a case report

Successful treatment with efgartigimod as an add-on therapy for acute attack of anti-NMDA receptor encephalitis: a case report

Abstract Background Anti-NMDA receptor encephalitis is an autoimmune, antibody-mediated inflammatory disease of the brain characterized by the presence of IgG antibodies targeting the excitatory N-methyl-D-aspartate receptor (NMDAR). Previous research has established that the neonatal Fc receptor (F...

Full description

Saved in:

Bibliographic Details
Main Authors:	Huasheng Huang, Yizhi Wei, Huihui Qin, Guangshun Han, Jie Li
Format:	Article
Language:	English
Published:	BMC 2025-01-01
Series:	BMC Neurology
Subjects:	Anti-NMDA-receptor antibody encephalitis Efgartigimod FcRn inhibitor IgG
Online Access:	https://doi.org/10.1186/s12883-025-04034-6
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Interactions of the anti-FcRn monoclonal antibody, rozanolixizumab, with Fcγ receptors and functional impact on immune cells in vitro
by: Omar S. Qureshi, et al.
Published: (2024-12-01)

Exploring molecular determinants and pharmacokinetic properties of IgG1-scFv bispecific antibodies
by: Kristina M.J. Aertker, et al.
Published: (2024-12-01)

Insight into the avidity–affinity relationship of the bivalent, pH-dependent interaction between IgG and FcRn
by: Johannes Reusch, et al.
Published: (2024-12-01)

Reducing neonatal Fc receptor binding enhances clearance and brain-to-blood ratio of TfR-delivered bispecific amyloid-β antibody
by: Eva Schlein, et al.
Published: (2024-12-01)

Monoclonal anti-CD38 therapy in human myeloma: retrospects and prospects
by: Alberto L. Horenstein, et al.
Published: (2025-02-01)

Systematic analysis of Fc mutations designed to reduce binding to Fc-gamma receptors
by: Geoff Hale, et al.
Published: (2024-12-01)

Association between leukocyte telomere length and specific antibody levels after vaccination against tick-borne encephalitis
by: N. S. Yudin, et al.
Published: (2020-01-01)

Systematic analysis of Fc mutations designed to enhance binding to Fc-gamma receptors
by: Geoff Hale, et al.
Published: (2024-12-01)

Case report: Successful perioperative intervention with efgartigimod in a patient in myasthenic crisis
by: Shahar Shelly
Published: (2025-01-01)

Immunomediated Encephalitis: New Diagnoses on the Neurology–Psychiatry Interface
by: Daniel Damiani, et al.

ASSOCIATION BETWEEN POLYMORPHISMS IN GENES ENCODING 2′-5′-OLIGOADENYLATE SYNTHETASES AND THE HUMORAL IMMUNE RESPONSE UPON VACCINATION AGAINST TICK-BORNE ENCEPHALITIS
by: N. S. Yudin, et al.
Published: (2018-07-01)

RUBY® – a tetravalent (2+2) bispecific antibody format with excellent functionality and IgG-like stability, pharmacology and developability properties
by: Barnabas Nyesiga, et al.
Published: (2024-12-01)

Therapeutic efficacy of a potent anti-Venezuelan equine encephalitis virus antibody is contingent on Fc effector function
by: Jennifer L. Schwedler, et al.
Published: (2024-12-01)

Anti-Tick-Bourne Encephalitis IgM Intrathecal Synthesis as a Prediction Marker in Tick-Borne Encephalitis Patients
by: Piotr Czupryna, et al.
Published: (2025-01-01)

Comparative Analysis of Hemagglutination Inhibition and Plaque Reduction Neutralization Tests for Japanese Encephalitis Virus Antibody Detection
by: Cui Li, et al.
Published: (2025-01-01)

Study on the correlation between serum IgG4/IgG levels and the development of Graves’ ophthalmopathy
by: Yuanyuan Deng, et al.
Published: (2025-01-01)

Evaluation of naturally occurring IgG anti-Vi antibody titers as predictors and correlates of typhoid fever in Dhaka, Bangladesh
by: Farhana Khanam, et al.
Published: (2025-01-01)

Does Clostridium Perfringens Epsilon Toxin Mimic an Auto-Antigen Involved in Multiple Sclerosis?
by: Marie-Lise Gougeon, et al.
Published: (2025-01-01)

Anti-LGI1 antibody autoimmune encephalitis. Clinical case presentation and literature review
by: A. Stašaitytė, et al.
Published: (2021-03-01)

Multivariate quantitative analysis of glycan impact on IgG1 effector functions
by: Tamara Cvijić, et al.
Published: (2024-12-01)

Improving the N-glycosylation occupancy of plant-produced IgG1 by engineering the amino acid environment at Asn297
by: Kathrin Göritzer, et al.
Published: (2025-01-01)

Glutamine-glutamate centered metabolism as the potential therapeutic target against Japanese encephalitis virus-induced encephalitis
by: Mengyuan Li, et al.
Published: (2025-01-01)

Site-specific immunoglobulin G N-glycosylation is associated with gastric cancer progression
by: Tingting Xu, et al.
Published: (2025-02-01)

With great power, comes great responsibility: the importance of broadly measuring Fc-mediated effector function early in the antibody development process
by: Silvia Crescioli, et al.
Published: (2025-12-01)

Magnesium in pain control - mechanisms of action in perioperative pain, neuropathic pain and migraine
by: Anna Konarska, et al.
Published: (2025-02-01)

Successful sequential therapy with rituximab and telitacicept in refractory Anti-NMDA receptor encephalitis and MOG-associated demyelination: a case report and literature review
by: Jingliang Zhang, et al.
Published: (2025-02-01)

Comparison of IgG and Neutralizing Antibody Response After Pfizer BioNTech COVID-19 Vaccine Among Iraqi Individuals
by: Najat Saeed Hussein, et al.
Published: (2023-06-01)

Editorial: T and B cell immune dynamics in allergic response
by: Mrinmoy Das, et al.
Published: (2025-02-01)

Onchocerciasis is not a major cause of blindness in two endemic villages in Sierra Leone
by: Ibrahim Kargbo-Labour, et al.
Published: (2025-01-01)

COVID-19 infection: neurological symptoms and encephalitis
by: A. Jasionis, et al.
Published: (2020-06-01)

Severe anti-α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor encephalitis with prolonged hyperammonemia: a case report
by: Chunxia Yan, et al.
Published: (2025-01-01)

Evaluación y rehabilitación de un caso de encefalitis por anticuerpos antirreceptor de N-metil-D-aspartato (NMDA), perspectiva neuropsicológica.
by: Ignacio Dopico González, et al.
Published: (2018-01-01)

Complement protein and Immunoglobulins Serum levels in Normal Pregnant and Spontaneous Aborted Women
by: Hiwa Abdulrahman Ahmad, et al.
Published: (2018-07-01)

Tracking Immunity: An Increased Number of COVID-19 Boosters Increases the Longevity of Anti-RBD and Anti-RBD-Neutralizing Antibodies
by: Ching-Wen Hou, et al.
Published: (2025-01-01)

Clinical features of autonomic dysfunction in children with anti-N-methyl-D aspartic receptor encephalitis
by: Dongqing Li, et al.
Published: (2025-01-01)

Clinical characteristics, diagnosis, treatment, and prognosis of Atezolizumab-induced encephalitis, aseptic meningitis or meningoencephalitis
by: Qingzi Yan, et al.
Published: (2025-01-01)

Telomerase and cells youth.
by: Alexander Benavides Couto, et al.
Published: (2008-08-01)

Tick-borne encephalitis: students’ attitude and knowledge analysis
by: R. Mineikytė, et al.
Published: (2018-06-01)

Characterization of Vaccine-Enhanced Humoral Immune Responses Against Emergent SARS-CoV-2 Variants in a Convalescent Cohort
by: Jared Sheehan, et al.
Published: (2025-01-01)

Isotype diversity of antibodies specific for component allergens in the context of allergic diseases: eosinophilic esophagitis (EoE), asthma, and the alpha-gal syndrome (AGS)
by: Thomas A. E. Platts-Mills, et al.
Published: (2025-02-01)